首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Successful pregnancy following busulfan and cyclophosphamide conditioning and allogeneic bone marrow transplantation for chronic myeloid leukemia.
【24h】

Successful pregnancy following busulfan and cyclophosphamide conditioning and allogeneic bone marrow transplantation for chronic myeloid leukemia.

机译:白消安和环磷酰胺调理以及同种异体骨髓移植治疗慢性粒细胞白血病后成功怀孕。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recovery of gonadal function in patients after allogeneic stem cell transplantation for hematologic malignancies is uncommon, and only a few cases have been reported. We report the case of a 39-year-old woman who had a normal full-term delivery 8 years after allogeneic bone marrow transplantation for chronic myeloid leukemia. Conditioning consisted of cyclophosphamide 120 mg/kg over 2 days and Busulfan 16 mg/kg over 4 days (BuCy). To our knowledge, this is the second reported case of pregnancy after BuCy conditioning.An increasing number of young women suffering from leukemia and other malignant and nonmalignant disorders are being cured by stem cell transplantation (SCT), raising the concern of late adverse effects of this procedure. These young people often wish to resume a high quality of life, and usually wish to have children. Most pretransplant conditioning protocols include alkylating agents, irradiation, or both, either of which can cause germinal epithelium depletion and infertility . In the nontransplant setting, the frequency of early menopause, azoospermia and germ cell destruction varies with the type and total dose of alkylating agent or irradiation, as well as patient sex and age at the time of treatment administration . Despite the gonadal toxicity of SCT, the literature documents successful pregnancies after therapy; however, the true incidence of pregnancy and pregnancy-related complications after transplantation are unknown [4-11].
机译:异基因干细胞移植治疗血液系统恶性肿瘤后患者性腺功能的恢复并不常见,只有少数病例报道。我们报道了一名39岁的妇女,该人在异基因骨髓移植后的慢性粒细胞白血病8年后正常足月分娩。调理包括2天之内的环磷酰胺120 mg / kg和4天之内的白消安16 mg / kg(BuCy)。据我们所知,这是BuCy调理后第二例报道的妊娠病例。越来越多的患有白血病以及其他恶性和非恶性疾病的年轻女性正在通过干细胞移植(SCT)治愈,这引起了人们对这种药物后期不良反应的担忧。这个程序。这些年轻人通常希望恢复高质量的生活,并且通常希望生育。移植前的大多数调理规程包括烷化剂,辐照或两者,这两种均可导致生发上皮耗竭和不育。在非移植设置中,更年期早期,无精子症和生殖细胞破坏的频率随烷基化剂或放射线的类型和总剂量以及治疗时患者的性别和年龄而变化。尽管有SCT的性腺毒性,但文献记载治疗后成功怀孕。然而,真正的怀孕发生率和移植后与怀孕相关的并发症尚不清楚[4-11]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号